The findings from this study are expected to provide insights into the primary resistance mechanisms, thereby improving our understanding of how tumor microenvironment dynamics contribute to treatment outcomes in ALK-positive NSCLC. The gene discussed is ALK; the disease is non-small cell lung carcinoma.